ChinaDaily Briefs

Daily Brief China: Sino Land Co, Hang Seng Index, Kanzhun , Migao Group Holdings and more

In today’s briefing:

  • HK CEO & Director Dealings (15 Mar 2024): Sino Land, Hysan, FE Consortium, Champion REIT, Dongyue
  • EQD | Hang Seng (HSI): How Far Can It Rally Now?
  • [Kanzhun Ltd. (BZ US, BUY, TP US$22) Rating Change]: Market Share Gain Ahead of Purported Recovery
  • Migao Group IPO – Last Listing Didn’t Do Well, This One Might Struggle Too


HK CEO & Director Dealings (15 Mar 2024): Sino Land, Hysan, FE Consortium, Champion REIT, Dongyue

By David Blennerhassett


EQD | Hang Seng (HSI): How Far Can It Rally Now?

By Nico Rosti

  • The Hang Seng Index is rallying and could co higher this week but it seems there isn’t much room to go really higher.
  • A good target to cover your LONG holdings would be 17500, for this coming week and/or the following week.
  • A pullback this coming week is also possible, so it’s not sure the index can rally more from here, or at least not without some correction first.

[Kanzhun Ltd. (BZ US, BUY, TP US$22) Rating Change]: Market Share Gain Ahead of Purported Recovery

By Eric Wen

  • BZ reported 4Q23 revenue in-line/2.6% vs. our estimate/consensus, non-GAAP NI beat our estimate/consensus by 3.5%/21.9%, mainly attributable to effective cost control measures. 
  • We think the competitive advantages over peers grand BZ privilege to enjoy the early sign of hiring demand recovery, whereas overall China job market remains lackluster in early 2024.
  • We upgrade the stock from SELL to BUY and rise TP by US$7.5 to US$22/ADS.

Migao Group IPO – Last Listing Didn’t Do Well, This One Might Struggle Too

By Clarence Chu

  • Migao Group Holdings (9879 HK) is looking to raise up to US$124m in its Hong Kong IPO.
  • Migao Group (Migao) is a vertically-integrated national potash fertilizer company in China.
  • In this note, we look at the firm’s past performance and share our thoughts on valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars